Osteoblast-Targeted Overexpression of TAZ Increases Bone Mass In Vivo

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Yang, Jae Yeon ^a   Cho, Sun Wook ^a   An, Jee Hyun ^a   Jung, Ju Yeon ^a   Kim, Sang Wan ^a   Kim, Seong Yeon ^a   Kim, Jung Eun ^b   Shin, Chan Soo ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; COLLAGEN TYPE 1; OSTEOCALCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMAD3 PROTEIN; SMAD4 PROTEIN; TAZ PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; PDZ DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; BONE AND BONES; BONE RESORPTION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; GENE EXPRESSION; GENE ORDER; GENETIC VECTORS; MICE; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOGENESIS; PHENOTYPE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES;

EID: 84874158519     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056585     Document Type: Article

References (40)

1. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, et al. (1991) Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113: 681-687.
2. Tapscott SJ, Weintraub H, (1991) MyoD and the regulation of myogenesis by helix-loop-helix proteins. J Clin Invest 87: 1133-1138.
3. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G, (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
4. Wu Z, Bucher NL, Farmer SR, (1996) Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol Cell Biol 16: 4128-4136.
5. Yeh WC, Cao Z, Classon M, McKnight SL, (1995) Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9: 168-181.
6. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, et al. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.
7. Jeon MJ, Kim JA, Kwon SH, Kim SW, Park KS, et al. (2003) Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J Biol Chem 278: 23270-23277.
8. Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, et al. (1999) Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem 74: 357-371.
9. Kim SW, Her SJ, Kim SY, Shin CS, (2005) Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Biochemical and Biophysical Research Communications 327: 811-819.
10. Cho SW, Yang JY, Her SJ, Choi HJ, Jung JY, et al. (2011) Osteoblast-targeted overexpression of PPARgamma inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 26: 1939-1952.
11. Zhang X, Yang M, Lin L, Chen P, Ma KT, et al. (2006) Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose-derived stem cells in vitro and in vivo. Calcified tissue international 79: 169-178.
12. Ichida F, Nishimura R, Hata K, Matsubara T, Ikeda F, et al. (2004) Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. The Journal of biological chemistry 279: 34015-34022.
13. Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, et al. (2000) TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. The EMBO journal 19: 6778-6791.
14. Wang K, Degerny C, Xu M, Yang XJ, (2009) YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochemistry and cell biology = Biochimie et biologie cellulaire 87: 77-91.
15. Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y, (1999) A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. The EMBO journal 18: 2551-2562.
16. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, et al. (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309: 1074-1078.
17. Jung H, Lee MS, Jang EJ, Ahn JH, Kang NS, et al. (2009) Augmentation of PPARgamma-TAZ interaction contributes to the anti-adipogenic activity of KR62980. Biochemical Pharmacology 78: 1323-1329.
18. Cui CB, Cooper LF, Yang X, Karsenty G, Aukhil I, (2003) Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Molecular and cellular biology 23: 1004-1013.
19. Byun MR, Kim AR, Hwang JH, Sung MK, Lee YK, et al. (2012) Phorbaketal A stimulates osteoblast differentiation through TAZ mediated Runx2 activation. FEBS letters 586: 1086-1092.
20. Makita R, Uchijima Y, Nishiyama K, Amano T, Chen Q, et al. (2008) Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. American journal of physiology Renal physiology 294: F542-553.
21. Thirunavukkarasu K, Mahajan M, McLarren KW, Stifani S, Karsenty G, (1998) Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Mol Cell Biol 18: 4197-4208.
22. Erben RG, (1997) Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society 45: 307-313.
23. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, et al. (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 2: 595-610.
24. Murakami M, Tominaga J, Makita R, Uchijima Y, Kurihara Y, et al. (2006) Transcriptional activity of Pax3 is co-activated by TAZ. Biochemical and biophysical research communications 339: 533-539.
25. Mahoney WM Jr, Hong JH, Yaffe MB, Farrance IK, (2005) The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. The Biochemical journal 388: 217-225.
26. Park KS, Whitsett JA, Di Palma T, Hong JH, Yaffe MB, et al. (2004) TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. The Journal of biological chemistry 279: 17384-17390.
27. Murakami M, Nakagawa M, Olson EN, Nakagawa O, (2005) A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proceedings of the National Academy of Sciences of the United States of America 102: 18034-18039.
28. Hong JH, Yaffe MB, (2006) TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell cycle 5: 176-179.
29. Hossain Z, Ali SM, Ko HL, Xu J, Ng CP, et al. (2007) Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proceedings of the National Academy of Sciences of the United States of America 104: 1631-1636.
30. Ciavarella S, Dammacco F, De Matteo M, Loverro G, Silvestris F, (2009) Umbilical cord mesenchymal stem cells: role of regulatory genes in their differentiation to osteoblasts. Stem cells and development 18: 1211-1220.
31. Felson DT, Zhang Y, Hannan MT, Anderson JJ, (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8: 567-573.
32. Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, et al. (2008) TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nature cell biology 10: 837-848.
33. Zimmermann G, Henle P, Kusswetter M, Moghaddam A, Wentzensen A, et al. (2005) TGF-beta1 as a marker of delayed fracture healing. Bone 36: 779-785.
34. Devescovi V, Leonardi E, Ciapetti G, Cenni E, (2008) Growth factors in bone repair. La Chirurgia degli organi di movimento 92: 161-168.
35. Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, et al. (2010) The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 18: 579-591.
36. Boban I, Jacquin C, Prior K, Barisic-Dujmovic T, Maye P, et al. (2006) The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells. Bone 39: 1302-1312.
37. Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, et al. (2001) Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. The Journal of cell biology 155: 157-166.
38. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P, (2002) High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Molecular and cellular biology 22: 6222-6233.
39. Jang EJ, Jeong H, Kang JO, Kim NJ, Kim MS, et al. (2012) TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ. British journal of pharmacology 165: 1584-1594.
40. Dhananjayan SC, Ramamoorthy S, Khan OY, Ismail A, Sun J, et al. (2006) WW domain binding protein-2, an E6-associated protein interacting protein, acts as a coactivator of estrogen and progesterone receptors. Molecular endocrinology 20: 2343-2354.